Cytotoxicity of folic acid conjugated hollow silica nanoparticles toward Caco2 and 3T3 cells, with and without encapsulated DOX

© 2016 Elsevier B.V. Hollow silica nanoparticles of two sizes with and without a folic acid targeting ligand were synthesized. Fickian diffusion of the antitumor drug doxorubicin hydrochloride (DOX) was demonstrated by the produced nanoparticles, achieving a cumulative release of 73% and 45% for 215...

Full description

Bibliographic Details
Main Authors: Patel, Kunal, Sundara Raj, Behin, Chen, Yan, Lou, Xia
Format: Journal Article
Published: 2016
Online Access:http://hdl.handle.net/20.500.11937/16470
_version_ 1848749185908604928
author Patel, Kunal
Sundara Raj, Behin
Chen, Yan
Lou, Xia
author_facet Patel, Kunal
Sundara Raj, Behin
Chen, Yan
Lou, Xia
author_sort Patel, Kunal
building Curtin Institutional Repository
collection Online Access
description © 2016 Elsevier B.V. Hollow silica nanoparticles of two sizes with and without a folic acid targeting ligand were synthesized. Fickian diffusion of the antitumor drug doxorubicin hydrochloride (DOX) was demonstrated by the produced nanoparticles, achieving a cumulative release of 73% and 45% for 215nm and 430nm particles respectively over a period of 500h. The hollow silica nanoparticles presented a time and dose dependent toxicity, selective to human epithelial colorectal adenocarcinoma (Caco2) cells, over mouse embryonic fibroblast (3T3) cells. At 24h Caco2 cell viability was reduced to 66% using pure hollow silica at a concentration of 50µgmL-1, while that of 3T3 cells remained at 94% under the same conditions. The selective cytotoxicity of hollow silica nanoparticles was further enhanced by conjugation of folic acid and incorporation of DOX: at 24h and an equivalent DOX concentration of 0.5µgmL-1, viable Caco2 cells were reduced to 45% while 3T3 cells were reduced to 83%. Interestingly the equivalent dose of free DOX was more toxic to 3T3 than to Caco2 cells, reducing the 3T3 viability to 72% and the Caco2 viability to 80%, which is likely due to the presence of the p-glycoprotein pumps in Caco2 cells. Folic acid conjugation served to enhance the viability of both cell lines in this work. Careful optimization of the folate content should further improve the cell specificity of the hollow silica nanoparticles, thus providing a viable targeting platform for cancer therapy.
first_indexed 2025-11-14T07:16:56Z
format Journal Article
id curtin-20.500.11937-16470
institution Curtin University Malaysia
institution_category Local University
last_indexed 2025-11-14T07:16:56Z
publishDate 2016
recordtype eprints
repository_type Digital Repository
spelling curtin-20.500.11937-164702017-09-13T15:04:45Z Cytotoxicity of folic acid conjugated hollow silica nanoparticles toward Caco2 and 3T3 cells, with and without encapsulated DOX Patel, Kunal Sundara Raj, Behin Chen, Yan Lou, Xia © 2016 Elsevier B.V. Hollow silica nanoparticles of two sizes with and without a folic acid targeting ligand were synthesized. Fickian diffusion of the antitumor drug doxorubicin hydrochloride (DOX) was demonstrated by the produced nanoparticles, achieving a cumulative release of 73% and 45% for 215nm and 430nm particles respectively over a period of 500h. The hollow silica nanoparticles presented a time and dose dependent toxicity, selective to human epithelial colorectal adenocarcinoma (Caco2) cells, over mouse embryonic fibroblast (3T3) cells. At 24h Caco2 cell viability was reduced to 66% using pure hollow silica at a concentration of 50µgmL-1, while that of 3T3 cells remained at 94% under the same conditions. The selective cytotoxicity of hollow silica nanoparticles was further enhanced by conjugation of folic acid and incorporation of DOX: at 24h and an equivalent DOX concentration of 0.5µgmL-1, viable Caco2 cells were reduced to 45% while 3T3 cells were reduced to 83%. Interestingly the equivalent dose of free DOX was more toxic to 3T3 than to Caco2 cells, reducing the 3T3 viability to 72% and the Caco2 viability to 80%, which is likely due to the presence of the p-glycoprotein pumps in Caco2 cells. Folic acid conjugation served to enhance the viability of both cell lines in this work. Careful optimization of the folate content should further improve the cell specificity of the hollow silica nanoparticles, thus providing a viable targeting platform for cancer therapy. 2016 Journal Article http://hdl.handle.net/20.500.11937/16470 10.1016/j.colsurfb.2015.12.046 restricted
spellingShingle Patel, Kunal
Sundara Raj, Behin
Chen, Yan
Lou, Xia
Cytotoxicity of folic acid conjugated hollow silica nanoparticles toward Caco2 and 3T3 cells, with and without encapsulated DOX
title Cytotoxicity of folic acid conjugated hollow silica nanoparticles toward Caco2 and 3T3 cells, with and without encapsulated DOX
title_full Cytotoxicity of folic acid conjugated hollow silica nanoparticles toward Caco2 and 3T3 cells, with and without encapsulated DOX
title_fullStr Cytotoxicity of folic acid conjugated hollow silica nanoparticles toward Caco2 and 3T3 cells, with and without encapsulated DOX
title_full_unstemmed Cytotoxicity of folic acid conjugated hollow silica nanoparticles toward Caco2 and 3T3 cells, with and without encapsulated DOX
title_short Cytotoxicity of folic acid conjugated hollow silica nanoparticles toward Caco2 and 3T3 cells, with and without encapsulated DOX
title_sort cytotoxicity of folic acid conjugated hollow silica nanoparticles toward caco2 and 3t3 cells, with and without encapsulated dox
url http://hdl.handle.net/20.500.11937/16470